Structural and Signaling Requirements for BCR-ABL-Mediated Transformation and Inhibition of Apoptosis

REFERENCES

• Afar, D. E. H., A. Goga, J. McLaughlin, O. N. Witte, and C. L. Sawyers. 1994. Differential complementation of Bcr-Abl point mutants with c-Myc. Science 264:424–426.
   PubMed Web of Science ®Google Scholar
• Anderson, S. M., P. M. Carroll, and F. D. Lee. 1990. Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle. Oncogene 5:317–325.
   PubMed Web of Science ®Google Scholar
• Askew, D. S., R. A. Ashmun, B. C. Simmons, and J. L. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915–1922.
   PubMed Web of Science ®Google Scholar
• Askew, D. S., J. N. Ihle, and J. L. Cleveland. 1993. Activation of apoptosis associated with enforced Myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood 82:2079–2087.
   PubMed Web of Science ®Google Scholar
• Carlesso, N., J. D. Griffin, and B. J. Druker. 1994. Use of a temperature-sensitive mutant to define the biological effects of the p210 BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene 9:149–156.
   PubMed Web of Science ®Google Scholar
• Clarkson, B., and A. Strife. 1993. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Leukemia 7:1683–1721.
   PubMed Web of Science ®Google Scholar
• Cleveland, J. L., M. Dean, N. Rosenberg, J. Y. J. Wang, and U. R. Rapp. 1989. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of mu-rine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol. Cell. Biol. 9:5685–5695.
   PubMed Web of Science ®Google Scholar
• Collins, M. K. L., and A. Lopez Rivas. 1993. The control of apoptosis in mammalian cells. Trends Biochem. Sci. 18:307–309.
   PubMed Web of Science ®Google Scholar
• Collins, M. K. L., J. Marvel, P. Malde, and A. Lopez-Rivas. 1992. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J. Exp. Med. 176:1043–1051.
   PubMed Web of Science ®Google Scholar
• Daley, G. Q., and D. Baltimore. 1988. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210 BCR/ABL protein. Proc. Natl. Acad. Sci. USA 85:9312–9316.
   PubMed Web of Science ®Google Scholar
• Darzynkiewicz, Z., S. Bruno, G. Del Bino, W. Gorczyca, M. A. Hotz, P. Lassota, and F. Traganos. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry 13:795–808.
   PubMedGoogle Scholar
• Ellis, R. E., J. Y. Yuan, and H. R. Horvitz. 1991. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7:663–698.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., and T. D. Littlewood. 1993. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3:44–49.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119–128.
   PubMed Web of Science ®Google Scholar
• Fisher, D. E. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell 78:539–542.
   PubMed Web of Science ®Google Scholar
• Gishizky, M. L., D. Cortez, and A. M. Pendergast. GRB2 mutant proteins reverse BCR-ABL induced transformation. Proc. Natl. Acad. Sci. USA, in press.
   Google Scholar
• Heisterkamp, N., G. Jenster, J. ten Hoeve, D. Zovich, P. K. Pattengale, and J. Groffen. 1990. Acute leukemia in bcr/abl transgenic mice. Nature (London) 344:251–253.
   PubMed Web of Science ®Google Scholar
• Izquierdo, M., J. Downward, H. Otani, W. J. Leonard, and D. A. Cantrell. 1992. Interleukin (IL)-2 activation of p21ras in murine myeloid cells trans-fected with human IL-2 receptor β chain. Eur. J. Immunol. 22:817–821.
   PubMed Web of Science ®Google Scholar
• Kabarowski, J. H. S., P. B. Allen, and L. M. Wiedemann. 1994. A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells. EMBO J. 13:5887–5895.
   PubMed Web of Science ®Google Scholar
• Kinoshita, T., T. Yokota, K. Arai, and A. Miyajima. 1995. Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J. 14:266–275.
   PubMed Web of Science ®Google Scholar
• Korsmeyer, S. J. 1992. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu. Rev. Immunol. 10:785–807.
   PubMed Web of Science ®Google Scholar
• Laneuville, P., M. Timm, and A. T. Hudson. 1994. bcr-abl expression in 32D cl3(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors. Cancer Res. 54:1360–1366.
   PubMed Web of Science ®Google Scholar
• Li, W., R. Nishimura, A. Kashishian, A. G. Batzer, W. J. H. Kim, J. A. Cooper, and J. Schlessinger. 1994. A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase. Mol. Cell. Biol. 14:509–517.
   PubMed Web of Science ®Google Scholar
• Lotem, J., E. J. Cragoe, Jr., and L. Sachs. 1991. Rescue from programmed cell death in leukemic and normal myeloid cells. Blood 78:953–960.
   PubMed Web of Science ®Google Scholar
• Lotem, J., and L. Sachs. 1990. Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor β1 in normal and leukemic myeloid cells. Blood 76:1315–1322.
   PubMed Web of Science ®Google Scholar
• Maru, Y., and O. N. Witte. 1991. The BCR gene encodes a novel serine/ threonine kinase activity within a single exon. Cell 67:459–468.
   PubMed Web of Science ®Google Scholar
• Matsuguchi, T., R. Salgia, M. Hallek, M. Eder, B. Druker, T. J. Ernst, and J. D. Griffin. 1994. Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and Steel factor and is constitutively increased by p210 BCR/ABL. J. Biol. Chem. 269:5016–5021.
   PubMed Web of Science ®Google Scholar
• Matuoka, K., F. Shibasaki, M. Shibata, and T. Takenawa. 1993. Ash/Grb2, and SH2/SH3-containing protein, couples to signaling for mitogenesis and cytoskeletal reorganization by EGF and PDGF. EMBO J. 12:3467–3473.
   PubMed Web of Science ®Google Scholar
• McGahon, A., R. Bissonnette, M. Schmitt, K. M. Cotter, D. R. Green, and T. G. Cotter. 1994. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 83:1179–1187.
   PubMed Web of Science ®Google Scholar
• McWhirter, J. R., D. L. Galasso, and J. Y. J. Wang. 1993. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol. 13:7587–7595.
   PubMed Web of Science ®Google Scholar
• McWhirter, J. R., and J. Y. J. Wang. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12:1533–1546.
   PubMed Web of Science ®Google Scholar
• Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785–1792.
   PubMed Web of Science ®Google Scholar
• Palacios, R., and M. Steinmetz. 1985. IL3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41:727–734.
   PubMed Web of Science ®Google Scholar
• Pawson, T. 1995. Protein modules and signaling networks. Nature (London) 373:573–580.
   PubMed Web of Science ®Google Scholar
• Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
   PubMed Web of Science ®Google Scholar
• Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, T. Pawson, and P. G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93–104.
   PubMed Web of Science ®Google Scholar
• Pendergast, A. M. Unpublished data.
   Google Scholar
• Pendergast, A. M., M. L. Gishizky, M. H. Havlik, and O. N. Witte. 1993. SH1 domain autophosphorylation of p210 BCR/ABL is required for transformation but not growth factor independence. Mol. Cell. Biol. 13:1728–1736.
   PubMed Web of Science ®Google Scholar
• Pendergast, A. M., A. J. Muller, M. H. Havlik, Y. Maru, and O. N. Witte. 1991. BCR sequences essential for transformation by the BCR/ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine dependent manner. Cell 66:161–171.
   PubMed Web of Science ®Google Scholar
• Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai, N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, and M. L. Gishizky. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175–185.
   PubMed Web of Science ®Google Scholar
• Pollack, A., and G. Ciancio. 1991. Cell cycle phase-specific analysis of cell viability using Hoechst 33342 and propidium iodide after ethanol preservation, p. 19–24. In Z. Darzynkiewicz, and H. A. Crissman (ed.), Methods in cell biology. Academic Press, San Diego, Calif.
   Google Scholar
• Pronk, G. J., A. M. M. De Vries-Smits, L. Buday, J. Downward, J. A. Maassen, R. H. Medema, and J. L. Bos. 1994. Involvement of Shc in insulin-and epidermal growth factor-induced activation of p21ras. Mol. Cell. Biol. 14:1575–1581.
   PubMedGoogle Scholar
• Puil, L., J. Liu, G. Gish, G. Mbamalu, D. Bowtell, P. G. Pelicci, R. Arlinghaus, and T. Pawson. 1994. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 13:764–773.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan, L., and N. Rosenberg. 1989. abl genes. Biochim. Biophys. Acta 989:209–224.
   PubMedGoogle Scholar
• Reuther, G. W., H. Fu, L. D. Cripe, R. J. Collier, and A. M. Pendergast. 1994. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family. Science 266:129–133.
   PubMed Web of Science ®Google Scholar
• Rozakis-Adcock, M., R. Fernley, J. Wade, T. Pawson, and D. Bowtell. 1993. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature (London) 363:83–85.
   PubMed Web of Science ®Google Scholar
• Sachs, L., and J. Lotem. 1993. Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82:15–21.
   PubMed Web of Science ®Google Scholar
• Sato, N., K. Sakamaki, N. Terada, K. Arai, and A. Miyajima. 1993. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common β subunit responsible for different signaling. EMBO J. 12:4181–4189.
   PubMed Web of Science ®Google Scholar
• Satoh, T., W. J. Fantl, J. A. Escobedo, L. T. Williams, and Y. Kaziro. 1993. Platelet-derived growth factor receptor mediates activation of Ras through different signaling pathways in different cell types. Mol. Cell. Biol. 13:3706–3713.
   PubMed Web of Science ®Google Scholar
• Sawyers, C. L., W. Callahan, and O. N. Witte. 1992. Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70:901–910.
   PubMed Web of Science ®Google Scholar
• Shibuya, H., M. Yoneyama, J. Ninomiya-Tsuji, K. Matsumoto, and T. Taniguchi. 1992. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 70:57–67.
   PubMed Web of Science ®Google Scholar
• Skolnik, E. Y., C. H. Lee, A. Batzer, L. M. Vicentini, M. Zhuo, R. Daly, M. J. J. Myers, J. M. Backer, A. Ulrich, and M. F. White. 1993. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J. 12:1929–1936.
   PubMed Web of Science ®Google Scholar
• Smetsers, T. F. C. M., T. Skorski, L. T. F. van de Locht, H. M. C. Wessels, A. H. M. Pennings, T. de Witte, B. Calabretta, and E. J. B. M. Mensink. 1994. Antisense BCR-ABL oligonucleotides induce apoptosis in the Phila-delphia chromosome-positive cell line BV173. Leukemia 8:129–140.
   PubMed Web of Science ®Google Scholar
• Symonds, H., L. Krall, L. Remington, M. Saenz-Robles, S. Lowe, T. Jacks, and T. Van Dyke. 1994. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703–711.
   PubMed Web of Science ®Google Scholar
• Tauchi, T., S. Boswell, D. Leibowitz, and H. E. Broxmeyer. 1994. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to Ras activation pathway. J. Exp. Med. 179:167–175.
   PubMed Web of Science ®Google Scholar
• ten Hoeve, J., R. B. Arlinghaus, J. Q. Guo, N. Heisterkamp, and J. Groffen. 1994. Tyrosine phosphorylation of CRKL in Philadelphia1 leukemia. Blood 84:1731–1736.
   PubMed Web of Science ®Google Scholar
• Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462.
   PubMed Web of Science ®Google Scholar
• Troppmair, J., J. L. Cleveland, D. S. Askew, and U. R. Rapp. 1992. v-Raf/ v-Myc synergism in abrogation of IL-3 dependence: v-Raf suppresses apop-tosis. Curr. Top. Microbiol. Immunol. 182:453–459.
   PubMedGoogle Scholar
• Valtieri, M., D. J. Tweardy, D. Caracciolo, K. Johnson, F. Mavilio, S. Altmann, D. Santoli, and G. Rovera. 1987. Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J. Immunol. 138:3829–3835.
   Google Scholar
• Young, J. C., M. L. Gishizky, and O. N. Witte. 1991. Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line. Mol. Cell. Biol. 11:854–863.
   PubMed Web of Science ®Google Scholar